Travere Therapeutics, Inc. (TVTX)
27.29
-0.89
(-3.16%)
USD |
NASDAQ |
Mar 05, 16:00
27.01
-0.28
(-1.03%)
Pre-Market: 09:17
Travere Therapeutics Cash from Investing (TTM) : 27.89M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Revolution Medicines, Inc. | 118.06M |
| ICU Medical, Inc. | 122.23M |
| Intuitive Surgical, Inc. | 665.80M |
| Tandem Diabetes Care, Inc. | 72.88M |
| iRhythm Holdings, Inc. | -277.06M |